XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents [1] $ 62,975 $ 40,348
Cash and investments segregated and on deposit for regulatory purposes (including resale agreements of $13,096 and $14,904 at December 31, 2021 and 2020, respectively) 53,949 50,399
Receivables from brokerage clients — net 90,565 64,440
Available for sale securities (amortized cost of $391,482 and $330,248 at December 31, 2021 and 2020, respectively) 390,054 337,400
Bank loans — net 34,636 23,813
Equipment, office facilities, and property — net 3,442 2,883
Goodwill 11,952 11,952
Acquired intangible assets — net 9,379 9,991
Other assets 10,318 7,783
Total assets 667,270 549,009
Liabilities and Stockholders’ Equity    
Bank deposits 443,778 358,022
Payables to brokerage clients 125,671 104,201
Accrued expenses and other liabilities 17,791 17,094
Short-term borrowings 4,855 0
Long-term debt 18,914 13,632
Total liabilities 611,009 492,949
Stockholders’ equity:    
Preferred stock — $.01 par value per share; aggregate liquidation preference of $10,100 and $7,850 at December 31, 2021 and 2020, respectively 9,954 7,733
Additional paid-in capital 26,741 26,515
Retained earnings 25,992 21,975
Treasury stock, at cost — 180,959,274 and 193,577,648 shares at December 31, 2021 and 2020, respectively (5,338) (5,578)
Accumulated other comprehensive income (loss) (1,109) 5,394
Total stockholders’ equity 56,261 56,060
Total liabilities and stockholders’ equity 667,270 549,009
Common Stock [Member]    
Stockholders’ equity:    
Common stock 20 20
Nonvoting Common Stock [Member]    
Stockholders’ equity:    
Common stock $ 1 $ 1
[1] For more information on the nature of restrictions on restricted cash and cash equivalents, see Note 23.